NEUROPROTECTION IN SPINAL MUSCULAR ATROPHY (SMA) USING NEURAL STEM CELLS AS A THERAPEUTIC APPROACH
- 3 Years 2009/2012
- 257.900€ Total Award
The project objective is to contribute to the development of a stem cell therapy for Spinal Muscular Atrophy (SMA). SMA is a common motor neuron degeneration disorder, manifesting with progressive muscle weakness and paralysis and leading to death. It is caused by mutations in the survival motor neuron gene.
We will investigate the therapeutic potential of transplanted neural stem cells generated from human adult reprogrammed somatic stem cells (induced pluripotent stem cells) to ameliorate the phenotype of an SMA mouse model. We will also use stem cells that are genetically modified to secrete growth factors and become more supportive to the motor neurons that die in SMA. The cells will be transplanted into the spinal cord of SMA mice, and we will evaluate whether and how their engraftment modifies disease progression.
These experiments in the SMA mouse model explore the feasibility of stem cell therapy for SMA and other motor neuron diseases.
Scientific Publications
- 2010 CELLULAR AND MOLECULAR LIFE SCIENCES
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells
- 2012 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies
- 2012 SCIENCE TRANSLATIONAL MEDICINE
Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy
- 2012 EXPERIMENTAL CELL RESEARCH
Direct reprogramming of human astrocytes into neural stem cells and neurons
- 2014 CLIN THER
Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Delta 7 Mouse Model Phenotype
- 2011 PROGRESS IN NEUROBIOLOGY
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development